Pembrolizumab plus chemoradiotherapy improved survival in patients with previously untreated, high-risk locally advanced ...

Pembrolizumab combined with chemoradiotherapy followed by pembrolizumab monotherapy significantly improved survival compared ...

The combination of belrestotug and dostarlimab significantly improved response rates in patients with previously untreated ...

Study findings support tivozanib monotherapy for second-line treatment of certain patients with metastatic RCC, an expert ...

Global demand for oil is slowing "sharply", the International Energy Agency said on Thursday, as it trimmed annual growth forecasts. The Paris-based body said demand rose by 800,000 barrels per day ...

Lexington ranks in the top 10 among mid-size U.S. cities for attracting Generation Z graduates to live and begin their work ...

Gilead Sciences’ capsid inhibitor lenacapavir has the most competitive potential in long-acting combination regimens in HIV, ...

GSK licensed the drug from long-standing partner Ionis as part of a two-drug deal in 2019, paying $25 million upfront with milestone payments taking the value of the deal up to $262 million.

Immatics has become the latest partner for GSK in the area of cell therapy for cancer to see its alliance shelved, just two and a half years after being set up. In its third-quarter results update ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

More than 18 inches of rain has been recorded in Carolina Beach, North Carolina. A system off the coast of the Carolinas is pummeling North Carolina with historic rainfall and life-threatening ...